Factors Affecting eGFR Slope of Renal Transplant Patients During the First 2 Years.


Journal

Transplantation proceedings
ISSN: 1873-2623
Titre abrégé: Transplant Proc
Pays: United States
ID NLM: 0243532

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 18 12 2018
accepted: 21 01 2019
pubmed: 12 8 2019
medline: 4 12 2019
entrez: 12 8 2019
Statut: ppublish

Résumé

In healthy individuals, glomerular filtration rate decreases by 1 mL/min/y after a peak level of 125.0 mL/min has been reached in adulthood. Any reduction greater than this is a progressive slope (slope more negative than -1 mL/min/y, stable [-1 to +1]), or an improvable slope if it shows more of an increase, that is, greater than +1.0 mL/min/y). The aim of the study was to determine the factors affecting estimated glomerular filtration rate (eGFR) slope during the first 2 years of renal transplant in patients with negative pretransplant panel-reactive antibody. The characteristics of 59 renal transplant patients, such as age, sex, etiology, and 2 years of laboratory data, were collected retrospectively. For each patient, the eGFR decline rate (slope) (mL/min-1/1.73 m Of 59 patients, 7 (11.8%) had a progressive slope, 22 (37.2%) had a stable slope, and 30 (50.8%) had an improvable slope. The first-year mean tacrolimus level was lower in patients with progressive slope than in the patients with stable slope and improvable slope (P < .022). The determinants of eGFR slope in multiple regression analysis were post-transplant hypertension (β = -0.393; P = .002) and the first-year mean tacrolimus level (β = 0.320; P = .01), whereas age, serum albumin, and 2-year mean tacrolimus level did not reach the level of significance. Keeping tacrolimus levels high in the first year to prevent eGFR declining is important.

Identifiants

pubmed: 31400970
pii: S0041-1345(18)31758-5
doi: 10.1016/j.transproceed.2019.01.165
pii:
doi:

Substances chimiques

Immunosuppressive Agents 0
Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2318-2320

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Feyza Firat Atay (FF)

Nephrology, Inonu University, Malatya, Turkey.

Hulya Taskapan (H)

Radiology, Inonu University, Malatya, Turkey. Electronic address: hulyataskapan@yahoo.com.

Bayram Berktas (B)

Nephrology, Inonu University, Malatya, Turkey.

Okan Yildirim (O)

Radiology, Inonu University, Malatya, Turkey.

Murat Dogan (M)

General Surgery, Inonu University, Malatya, Turkey.

Turgut Piskin (T)

General Surgery, Inonu University, Malatya, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH